The DCT OS Report: More than 95% of biopharma executives say we're not going back to a site-based-only development model. Learn more


Science 37 puts a very high value on the relationships we have with clients, CROs, industry lobby groups, and patient advocacy groups. By partnering to enable interventional home-based clinical trials, we can optimize recruitment and enrollment, improve patient retention, and expand access to precision care.

It’s only by working together that we can accelerate drug development now and in the future.

Contact to find out more about becoming a Science 37 Certified partner or for additional information, please contact us at

CRO and Pharma Partnerships .

Science 37 can help clinical research organizations (CROs) that provide support to pharmaceutical, biotech and medical device companies in the form of outsourced research services expand access to patients, add diversity and mitigate risk with a decentralized model that is centered around the patient.

  • 3H Medi Solution
  • CMIC
  • Syneos Health
  • PPD
  • Genentech
  • Sanofi
  • Otsuka
  • Novartis
  • UCB
  • Boehringer-Ingelheim
  • Janssen

Industry Partnerships .

Through our partnerships with industry groups, we’re making clinical trials more accessible and available to more patients around the world, and accelerating the development of treatment in order to make a difference in their lives.

  • Women of Color in Pharma
  • AiCure
  • Advarra
  • Urban League
  • Signant Health
  • Medgate
  • Xperiome
  • ERT
  • Foundation Medicine
  • QOL Medical
  • Keck School of Medicine of USC